Skip to content
★ Sign in to follow
Insider activity · 24 months0 buys8 salesCumulative net flow
Total declarations
30
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€3.2M

Latest filing published 15 Apr 2026 for Disc Medicine, Inc., €23k.

Filing timeline

BuySale
Jean M. Franchi

Insider track record

Disclosed buys
0
Disclosed sells
18

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Jean M. Franchi: trading record in brief

Jean M. Franchi, listed as finance chief, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Replimune Group, Inc., Disc Medicine, Inc. and Biodesix Inc. We count 30 filings; the first trade dates from 14 December 2020 and the latest from 14 April 2026.

Every open-market trade on record is a sale: 18 sales worth €3.2M. Besides market trades, the filings include 7 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 6 sales.

On 15 April 2026 came the latest disclosure, an open-market sale for €23k in Disc Medicine, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jean M. Franchi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

18 of 18 declarations